Data from EPG Health Media - Curated by Toby Galbraith - Last updated 24 November 2017

Browse related ATC

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
OTHER ANTINEOPLASTIC AGENTS
Protein kinase inhibitors
imatinib
gefitinib
erlotinib
sunitinib
sorafenib
dasatinib
lapatinib
nilotinib
temsirolimus
everolimus
pazopanib
vandetanib
afatinib
bosutinib
vemurafenib
crizotinib
axitinib
ruxolitinib
ridaforolimus
regorafenib
masitinib
dabrafenib
ponatinib
trametinib
cabozantinib
ibrutinib
ceritinib

Drug

Imatinib Actavis (Imatinib)

ATC
Orphan drug
No

Updated 6 months ago

Imatinib Teva (Imatinib)

ATC
Orphan drug
No

Updated 9 months ago

Imatinib Accord (Imatinib)

ATC
Orphan drug
No

Updated 4 months ago

Cabometyx (Cabozantinib)

ATC
Orphan drug
No

Updated 11 months ago

Imatinib medac (Imatinib)

ATC
Orphan drug
No

Updated 6 months ago

Zykadia▼ (Ceritinib)

ATC
Orphan drug
No

Updated 2 months ago

Imbruvica▼ (Ibrutinib)

ATC
Orphan drug
Yes

Updated 1 month ago

Stivarga▼ (Regorafenib)

ATC
Orphan drug
No

Updated 2 months ago

Mekinist▼ (Trametinib)

ATC
Orphan drug
No

Updated 2 months ago

Cometriq▼ (Cabozantinib)

ATC
Orphan drug
Yes

Updated 8 months ago